Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMARO: Mycophenolate Mofetil vs Azathioprine in Autoimmune Hepatitis
NCT02900443Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in autoimmune hepatitis (AIH) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Biochemical remission at 24 weeks. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT02900443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02900443.